Search results
Pfizer Jumps On 'Massive' First-Quarter Upside Thanks To Paxlovid Surprise
Investor's Business Daily· 1 day agoExcluding that, Paxlovid sales still topped expectations. Comirnaty, the Covid vaccine Pfizer...
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga· 3 hours agoThursday, Moderna Inc MRNA reported a first-quarter EPS loss of $(3.07), down from an income of...
TIME100 Health: Katalin Kariko and Drew Weissman
Time Magazine· 10 hours agoDr. Drew Weissman was working on developing an HIV vaccine, and Katalin Kariko was struggling to keep her lab open and convince her superiors that her...
Arbutus Biopharma Corp Reports Q1 2024 Earnings: A Detailed Financial Review
GuruFocus.com via Yahoo Finance· 9 hours agoLitigation and Intellectual Property Updates Arbutus continues to defend its intellectual property vigorously, particularly in ongoing litigation with Moderna and Pfizer/BioNTech< ...
Pfizer lifts profit view on cost cuts, demand for COVID products
Reuters· 1 day ago, opens new tab lifted its annual earnings forecast on Wednesday and reported a first-quarter profit...
Why Africa is facing an uphill battle to make its own vaccines
The Telegraph via Yahoo News· 1 day agoIt simply wasn’t affordable for the plans for a new plant to go ahead – something experts have...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 1 day agoSales also tumbled 20% to $14.88 billion, but topped forecasts for $13.87 billion. As expected,...
Unable to work since COVID vaccination, Gatineau man pins hopes on compensation
CBC via Yahoo News· 4 days agoA Gatineau, Que., man who developed a debilitating skin ailment after receiving a COVID-19 vaccine...
Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings
Zacks via Yahoo Finance· 3 days agoPfizer (PFE) expects its operational revenues to improve, driven by its in-line products like...
GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
Benzinga via Yahoo Finance· 1 day agoWednesday, GSK Plc (NYSE:GSK) reported first-quarter sales of $9.33 billion (7.4 billion Sterling...